Previous 10 | Next 10 |
2024-04-10 11:58:51 ET More on Estee Lauder, Hasbro, etc. Paramount Global's Sale Will Not Be Easy, Cheap, Or Fast Paramount: What The Skydance Proposal Means For Investors Paramount: Apollo Coming Around The Turn Ready To Pounce If Skydance Deal Falters ...
2024-04-08 09:07:13 ET More on iShares Russell 2500 ETF: Small- and mid-cap stocks with the biggest correlation to ISM - BofA Seeking Alpha’s Quant Rating on iShares Russell 2500 ETF Dividend scorecard for iShares Russell 2500 ETF Read the full artic...
2024-04-04 11:12:55 ET More on Health Care Select Sector SPDR: XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli...
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the first quarter of 2024 on May 9, 2024 after the close of the financial mar...
2024-04-02 15:30:31 ET More on S&P 500 Index: Manufacturers' Shipments February 2024: Weak, But Not Weak Enough Market Corrections Matter More Than You Think Don't Overcomplicate Things Major averages are on pace to close out worst day of trading in nearl...
2024-03-30 12:13:00 ET The Health Care Select Sector SPDR Fund ETF ( NYSEARCA: XLV ), tracking the healthcare companies under S&P 500, rose 8.32% in the first quarter of 2024, lagging slightly behind the broader S&P 500 index which rose 10.16%.... Read the full article...
2024-03-28 09:44:31 ET Summary Insulet Corporation, the maker of the Omnipod Insulin Management System, provides essential services to a patient group of 10 million diabetes patients and has experienced significant growth over the past decade. The company's wearable and discrete s...
2024-03-26 09:29:13 ET More on Tandem Diabetes Care Tandem Diabetes Care, Inc. (TNDM) Q4 2023 Earnings Call Transcript Tandem Diabetes Care GAAP EPS of -$0.46 misses by $0.19, revenue of $196.8M misses by $6.05M Seeking Alpha’s Quant Rating on Tandem Diabetes ...
2024-03-22 09:25:36 ET More on markets Nasdaq, S&P, and Dow futures notice limited movement while yields tick down Dividend Roundup: JPMorgan Chase, Starbucks, CVS Health, Mondelez, and more S&P 500 and 20% of its holdings flash overbought signals, according ...
2024-03-20 06:46:19 ET More on Insulet Insulet: An Interesting, Yet Expensive, Story Insulet Omnipod 5 insulin pump bests conventional delivery systems Insulet Non-GAAP EPS of $1.40 beats by $0.74, revenue of $509.8M beats by $48.74M Seeking Alpha’s Qu...
News, Short Squeeze, Breakout and More Instantly...
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the second quarter of 2024 on August 8, 2024 after the close of the financial...
Largest, longest, and most racially diverse study of automated insulin delivery (AID) conducted in people with type 2 diabetes to date Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® bra...
Following a successful limited market release, the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) is now fully available with Dexcom G6 and Abbott FreeStyle Libre 2 Plus in these countries Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tub...